PharmaShots | Incisive News in 3 Shots

Subscribe Now

Chemotherapy

Eli Lilly and Innovent Report the US FDA's Acceptance of Sintilimab + Chemotherapy's BLA for 1L Treatment for Non-Squamous NSCLC

Eli Lilly and Innovent Report the US FDA's Acceptance of Sintilimab + Chemotherapy's BLA for 1L Treatment for Non-Squamous NSCLC

May 18, 2021

Merck's Keytruda (pembrolizumab) + Chemotherapy Receive NMPA's (CFDA) Approval for 1L Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Merck's Keytruda (pembrolizumab) + Chemotherapy Receive NMPA's (CFDA) Approval for 1L Metastatic Non-Squamous Non-Small Cell Lung...

April 2, 2019

Merck's Keytruda + Chemotherapy Receive EU's Approval for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

Merck's Keytruda + Chemotherapy Receive EU's Approval for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

March 14, 2019

Merck Reports Improved Overall Survival Results of Keytruda (pembrolizumab) vs Chemotherapy in KEYNOTE-181 Study

Merck Reports Improved Overall Survival Results of Keytruda (pembrolizumab) vs Chemotherapy in KEYNOTE-181 Study

November 15, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us